Nomegestrol Eg (Nomegestrol Acetate)

Nomegestrol Acetate, the active ingredient in Nomegestrol Eg, is a progestin (synthetic progestogen) presented as an oral tablet for systemic use. It is employed as a progestogen‑only contraceptive and for hormone replacement therapy in menopausal women.

GNH USA supplies Nomegestrol Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nomegestrol Eg is a synthetic progestogen used in hormonal pathways related to contraception and menopause management.

Contraception: prevents pregnancy by suppressing ovulation and inducing endometrial changes that inhibit implantation. Hormone replacement therapy: relieves menopausal symptoms such as hot flashes and prevents endometrial hyperplasia in estrogen‑treated women.

Nomegestrol Eg may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Nausea: occasional upset stomach. - Breast tenderness: transient discomfort. - Weight gain: modest increase in body weight. - Mood changes: irritability or mild depression. - Irregular bleeding: spotting or breakthrough bleeding.

Serious or Rare Side Effects: - Venous thromboembolism: deep vein thrombosis or pulmonary embolism. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Depression: severe or persistent mood disorder. - Hypertension: new‑onset high blood pressure. - Uterine rupture: extremely rare, usually associated with uterine surgery.

Before initiating therapy with Nomegestrol Eg, clinicians should evaluate individual risk factors and counsel patients on safe use.

Assess thrombotic risk: avoid in patients with a history of venous thromboembolism. Evaluate liver function: monitor in patients with hepatic impairment. Monitor blood pressure: check regularly during treatment. Counsel on smoking cessation: smoking increases cardiovascular risk. Avoid use in pregnancy: contraindicated due to teratogenic potential. Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Nomegestrol Eg can interact with other medicines that affect its metabolism or pharmacodynamic profile.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce contraceptive efficacy. - Anticoagulants (e.g., warfarin): may alter anticoagulant control. - HIV protease inhibitors: potential for reduced hormonal activity.

Moderate Interactions (Monitor Closely): - Antifungals (e.g., ketoconazole, itraconazole): may increase plasma levels. - Macrolide antibiotics (e.g., erythromycin): possible modest increase in hormone exposure. - Antiepileptic drugs (e.g., phenytoin): may modestly decrease effectiveness.